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Objective: To study the correlation between miR-21 and Treg/Th17 ratio in the
microenvironment of rats with hepatocellular carcinoma.
Methods: Diethylnitrosamine was used to build the hepatocellular carcinoma model of
rats; the content of Treg cells and Th17 cells and the expression of miR-21 in the pe-
ripheral blood of rats with hepatocellular carcinoma were detected. The statistical analysis
was performed on the correlation between miR-21 expression and Treg/Th17 ratio.
Results: Hepatocellular carcinoma model of rats was successfully constructed. The
proportion of Th17 cells among all CD4+T cells in the peripheral blood of rats with
hepatocellular carcinoma was 5.319%, which was higher than the control group; while
the proportion of Treg cells was 9.472%, which was higher than the control group. Treg/
Th17 ratio in the model group was 1.781, compared with 1.478 in the control group. The
expression of miR-21 was increased in the peripheral blood of rats with hepatocellular
carcinoma and it showed a positive correlation with the ratio of Treg/Th17.
Conclusions: There is a positive correlation between the expression level of miR-21 and
the ratio of Treg/Th17.1. Introduction
The primary hepatocellular carcinoma is some kind of com-
mon malignant tumor and its pathogenesis is related to various
factors [1]. It is still difﬁcult to diagnose and treat such disease.
The current ﬁndings suggested that the tumor cells could evade
the immune surveillance and thus result in the occurrence and
development of tumor [2]. Two new subtypes of CD4+T cells,
Treg cell and Th17 cell, played the important regulatory role in
many tumors [3]. In recent years, many researches indicated
that the microRNA was closely related to the occurrence,
development and metastasis of hepatocellular carcinoma [4].
But it has been still unknown whether microRNA is related to
the immune balance in which Treg/Th17 join in and its speciﬁc
mechanism of molecular biology. In this study, relying on the
constructed hepatocellular carcinoma model of rats, we studiedthe correlation between the microRNA and Treg/Th17 cell
subsets in the microenvironment of rats with hepatocellular
carcinoma.
2. Materials and methods
2.1. Construction of hepatocellular carcinoma model of
rats
The diethylnitrosamine was purchased from Sigma Corpo-
ration. The normal saline was used to prepare diethylnitrosamine
as the solution with the concentration of 4 mg/mL, which was
kept in a dark place.
Fifty purchased male SD rats with the weight of 180–220 g
were randomly divided into two groups, namely the control
group (n = 10) and model group (n = 40).
The intraperitoneal injection of diethylnitrosamine was given
to rats in the model group (with the dosage of 20 mg/kg, while
the same dosage of normal saline to the control group), 3 times a
week and lasted for 12 wk. The dietetic condition, mental state,
and changes in the weight and clothing hair of experimental
animals were observed every day during the administration. Inen access article under the CC BY-NC-ND
Figure 1. Morphology of hepatocytes for hepatocellular carcinoma model
of rats in 16th week.
Table 1
Treg/Th17 ratio in the peripheral blood of hepatocellular carcinoma
model of rats.
Test index Control group (n = 10) Model group (n = 30)
Treg cell (%) 5.498 9.472***
Th17 cell (%) 3.721 5.319***
Treg/Th17 1.478 1.781***
Note: the content of Treg cells and Th17 cells in the table is expressed by
mean ± standard deviation. *** refers to P < 0.001.
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animals and then they were executed after anesthesia. After the
observation of laparotomy on the gross morphology of liver, the
liver was taken out and ﬁxed by formalin to prepare the parafﬁn-
embedded sections. The pathological examination was per-
formed on the liver after HE staining.
2.2. Detection of content of Th17 cell and Treg cell
Cells were collected in the EP tube for 5 min of centrifuga-
tion at 2 000 rpm. Then the supernate was decanted. It was
washed by PBS once. The process of centrifugation was
repeated to remove the supernate. Then the ﬂuorescent-labeled
CD4 antibody was added and it was kept in a dark place at
the room temperature for 30 min. It was washed by the proper
PBS and then centrifuged at 2 000 rpm for 5 min afterwards. The
supernate was decanted. Th17 cell and Treg cell were labeled
respectively. For Th17 cell, 100 mL Th17 permeabilization wash
buffer A was added and kept in a dark place at the room tem-
perature for 10 min. Then the proper content of PBS was added
for 5 min of centrifugation at 2 000 rpm. The supernate was
decanted. Then B solution was added by 100 mL. The
ﬂuorescent-labeled anti-IL-17 antibody was added and it was
kept in a dark place at the room temperature for 30 min of in-
cubation. It was washed by PBS once again. Then the proper
content of PBS was used to resuspend the cells. It was trans-
ferred to the ﬂow tube and analyzed on the machine. For Treg
cell, 500 mL Foxp3 permeabilization wash buffer was added and
kept in a dark place at 4 C for 30 min of incubation. Then it was
washed by the special buffer and centrifuged at 2 000 rpm for
5 min. The supernate was decanted. Five microlitres ﬂuorescent-
labeled anti-Foxp3 antibody was added and it was kept in a dark
place at the room temperature for 30 min of incubation. It was
washed by PBS. Then PBS was used to resuspend the cells and
it was transferred to the ﬂow tube and analyzed by the machine.
2.3. Real-time and quantitative PCR detection
Trizol method was adopted to extract and separate the total
RNA from the obtained PBMC cells. All test kits were purchased
from Promega. The reverse transcription was performed on
extracted RNA according to the operation procedure of reverse
transcription kit. Then the real-time and quantitative PCR detec-
tionwas carried out, where PCR instrument was ABI 7300 and the
used reagent was SYBR Green purchased from TOYOBO. The
matching primer of each gene was as follows: IL-17A F: 50-
TCCCACGAAATCCAGGATGC-30, R: 50-GGATGTT-
CAGGTTGACCATCAC-30; IL-17F F: 50- GCGTTTCCATGT-
CACGTAACA-30, R: 50- CAGCCCAAGTTCCTACACTGG-30;
Foxp3 F: 50- GTGGCCCGGATGTGAGAAG-30, R: 50-
GGAGCCCTTGTCGGATGATG-30. The speciﬁc primer for
miR-21 was purchased from RiboBio.
3. Results
3.1. Construction and evaluation of hepatocellular
carcinoma model of rats
As the administration time became longer, compared with
the control group, rats in the model group showed a signiﬁ-
cantly poorer mental state, decreased dietetic condition, slowlyincreased weight, sluggish reaction and messy and dull clothing
fair. According to the pathological examination in 16th week, it
could be seen that hepatocytes possessed the typical charac-
teristics of hepatocellular carcinoma such as the big nucleus
and deep staining. It also showed the signiﬁcant atypical hy-
perplasia to be arranged in the block or stripe pattern, as well as
the inﬁltrative growth to the normal hepatocytes around, as
shown in Figure 1. In this study, the mortality was controlled at
7.5% (3/40). In the 16th week, the cancer rate was up to 81.1%
(30/37).
3.2. Treg/Th17 ratio in the peripheral blood of
hepatocellular carcinoma model of rats
For the rats with hepatocellular carcinoma in the model
group, compared with the normal rats in the control group, the
ﬂow cytometer was adopted to analyze the content of Th17 cells
(CD4+, IL17+) and Treg cells (CD4+, Foxp3+) in the peripheral
blood. As shown in Table 1, the proportion of Th17 cells (CD4+,
IL17+) among all CD4+T cells in the peripheral blood of 30 rats
with hepatocellular carcinoma was 5.319%, while the one in the
normal rats was 3.721%, with the statistical difference
(P < 0.001); the proportion of Treg cells (CD4+, Foxp3+) among
all CD4+T cells in the peripheral blood of 30 rats with hepato-
cellular carcinoma was 9.472%, while the one in the normal rats
was 5.498%, with the statistical difference (P < 0.001). Ac-
cording to the analysis on Treg and Th17 cells in the model
group and control one, the ratio of Treg and Th17 for the rats in
the model group was 1.781, while the one in the control group
was 1.478, with the statistical difference (P < 0.001).
To further validate the experimental data, real-time and
quantitative PCR was employed to compare the mRNA level of
IL-17 and Foxp3 between the rats with hepatocellular carcinoma
in the model group and normal rats in the control group. As
shown in Figure 2, the expression of IL-17A, IL-17F and Foxp3
Figure 2. Expression of IL-17A, IL-17F and Foxp3 between two groups.
Control group: Ctrl; Model group: Cancer. * refers to P < 0.05.
Figure 4. Correlation between the content of miR-21 and ratio of Treg/
Th17 in the peripheral blood of hepatocellular carcinoma model of rats
(P < 0.001).
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control group, with the statistical difference (P < 0.05).
3.3. Correlation between expression of miR-21 and
Treg/Th17 ratio in the peripheral blood of
hepatocellular carcinoma model of rats
Among rats with cancer, there was the very speciﬁc expres-
sion proﬁle of microRNA in the peripheral blood, such as miR-
21, which was some kind of up-regulated microRNA in many
tumors. Besides, the content of miR-21 in the peripheral blood
of rats with hepatocellular carcinoma was also increased. In this
study, real-time and quantitative PCR was employed to detect
the expression of miR-21 in two groups. Results showed that the
content of miR-21 in the peripheral blood of rats in the model
group was signiﬁcantly higher than the one in the control group,
as shown in Figure 3.
Based on the ratio of Treg and Th17 and the content of miR-
21 in the peripheral blood of rats in the control group and model
one, the correlation between miR-21 and ratio of Treg/Th17 was
constructed. As shown in Figure 4, there was a positive corre-
lation between the content of miR-21 and ratio of Treg/Th17.
Such result indicated that the increased expression of miR-21
might contribute to the imbalance between Treg cells and
Th17 ones in rats with hepatocellular carcinoma.Figure 3. Expression of miR-21 between two groups.
Control group: Ctrl; Model group: Cancer. * refers to P < 0.05.4. Discussion
Th17 cells and Treg cells all belong to CD4+T lymphocytes,
but different from Th1 cells and Th2 cells. Th17 cells can secrete
the interleukin 17, which play the critical role in the pathogen-
esis of allergic diseases and autoimmune diseases.
CD4+CD25+Treg cells can resist the inﬂammation and maintain
the immune tolerance and thus keep the immune system in the
state of balance. Th17 cells and Treg cells restrain each other
functionally. For the autoimmune diseases, there is the immune
imbalance of Th17/Treg. The state of balance between them
plays an important role in maintaining the steady state of im-
mune system [5,6].
In recent years, ﬁndings showed that microRNA was of
critical importance in the occurrence and development of tumor
and its wide application could be expected in the future. The
abnormal expression of a series of microRNA in hepatocellular
carcinoma cells could play the role of ‘cancer gene’ or ‘tumor
suppressor gene’ [7]. MiR-21 is a microRNA that has been
studied much. Hu et al. reported that miR-21 could regulate the
target gene HEPN1 to promote the proliferation of hepatocel-
lular carcinoma cells [8]; Wang et al. found that the expression
level of miR-21 could predict the prognosis of hepatocellular
carcinoma [9]; Bao et al. found that miR-21 could inhibit the
expression of target gene PTEN and hSulf-1 and thus promote
the occurrence and development of hepatocellular carcinoma
through AKT/ERK signal pathway [10]. However, it still has
been unknown whether there is the correlation between miR-
21 and the imbalance of Th17 and Treg cells in the microen-
vironment of tumor.
At present, there are limited researches on the correlation
between microRNA and the imbalance of Th17 and Treg cells
in the microenvironment of tumor. Lv et al. reported that
miR141-CXCL1-CXCR2 signal-induced Treg recruitment
could regulate the metastasis and survival rate of non-small cell
lung cancer [11]; Dong et al. found that, in patients with
rheumatoid arthritis, there was the correlation between the
reduced expression of miR-21 and the imbalance of Th17
and Treg cells [12]. Though this study conﬁrmed the positive
correlation between the up-regulated expression of miR-21
and the ratio of Th17/Treg, it is still essential to study the
speciﬁc regulatory mechanism of molecular biology, in order to
provide the new target spots for the diagnosis and treatment of
diseases.
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